CRIP1 and neoplasm: We demonstrate that CRIP1‐mediated VEGFC can promote lymphangiogenesis in the tumor microenvironment and that GC cell‐derived CCL5 can also recruit TAM and enhance their secretion of tumor necrosis factor alpha (TNF‐α) which then increases the permeability of lymphatic vessel to facilitate LM of GC cells.